Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Catapult Therapeutics logo — Targeted therapy for cancer

Catapult Therapeutics

Targeted therapy for cancer

The Netherlands The Netherlands 1 employees Biotechnology

General Information

Company Name Catapult Therapeutics
Location The Netherlands The Netherlands +1
Founders / Decision Makers
Team member
Employees 1
Industries Biotechnology
Social

Get notified when Catapult Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Catapult Therapeutics

**Catapult Therapeutics** is a Dutch-based **biotech company** that specializes in the development of **targeted cancer therapy**. Their flagship product, CAP-100, is an **innovative first-in-class humanized anti-CCR7 antibody**. Despite the absence of publicly available data regarding their founding date, the company has positioned itself as a prominent player in the biotechnology sector. Based in **The Netherlands**, the company is poised to make significant strides in the field of cancer treatment. In terms of investments, the latest funding details for Catapult Therapeutics are currently unavailable. While the specific investment amount and the involved investors remain undisclosed, the company's focus on pioneering cancer treatment solutions positions it as an attractive prospect for venture capitalists seeking to make a meaningful impact in the biotechnology industry. With its promising approach to targeted cancer therapy, Catapult Therapeutics presents an intriguing opportunity for investors looking to support innovative solutions in the fight against cancer.

Taxonomy: biotech company, cancer therapy, immunotherapy, humanized antibody, oncology, pharmaceuticals, targeted therapy, precision medicine

No funding data available for Catapult Therapeutics yet.

Get notified when Catapult Therapeutics raises funding

Catapult Therapeutics Alternatives & Competitors

Catapult Therapeutics vs
BECKMAN & ASSOCIATES
BECKMAN & ASSOCIATES United States

Premier pediatric specialty therapy clinic

27 employees
Health Care, Health and Wellness
Catapult Therapeutics vs
Connect Teletherapy
Connect Teletherapy

Offering comprehensive online therapy solutions for schools and families, including speech, occupati...

Education, Health Care
Catapult Therapeutics vs
Healthy Families of Albuquerque
Healthy Families of Albuquerque United States

"Where Families Come to Heal."

14 employees
Health Care, Health and Wellness

FAQ About Catapult Therapeutics

Targeted therapy for cancer
Catapult Therapeutics is headquartered in The Netherlands.
Catapult Therapeutics operates in the following industries: Biotechnology.
Catapult Therapeutics has approximately 1 employees.
Top alternatives and competitors to Catapult Therapeutics include BECKMAN & ASSOCIATES, Connect Teletherapy, Healthy Families of Albuquerque, Leaps & Bounds Pediatric Therapy, Coastal Rehabilitation Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Catapult Therapeutics and BECKMAN & ASSOCIATES are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Catapult Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy